T-Cell Chauvinists Versus Antibody Advocates—Can't We All Just Get Along?
- 15 November 2004
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 22 (22), 4446-4448
- https://doi.org/10.1200/jco.2004.06.939
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Phase I Clinical Trial of the Immunocytokine EMD 273063 in Melanoma PatientsJournal of Clinical Oncology, 2004
- The Innate Mononuclear Phagocyte Network Depletes B Lymphocytes through Fc Receptor–dependent Mechanisms during Anti-CD20 Antibody ImmunotherapyThe Journal of Experimental Medicine, 2004
- Two Immunoglobulin G Fragment C Receptor Polymorphisms Independently Predict Response to Rituximab in Patients With Follicular LymphomaJournal of Clinical Oncology, 2003
- HER-2/neu-Specific Monoclonal Antibodies Collaborate with HER-2/neu-Targeted Granulocyte Macrophage Colony-Stimulating Factor Secreting Whole Cell Vaccination to Augment CD8+ T Cell Effector Function and Tumor-Free Survival in Her-2/neu-Transgenic MiceThe Journal of Immunology, 2003
- Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor LymphocytesScience, 2002
- Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa geneBlood, 2002
- Tumor immunity and autoimmunity induced by immunization with homologous DNA.Journal of Clinical Investigation, 1998
- 3F8 monoclonal antibody treatment of patients with stage 4 neuroblastoma: a phase II study.International Journal of Oncology, 1998
- Phase Ia/Ib Trial of Anti-GD2 Chimeric Monoclonal Antibody 14.18 (ch l4.18) and Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor (rhGM-CSF) in Metastatic MelanomaJournal of Immunotherapy, 1996
- Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma.Proceedings of the National Academy of Sciences, 1985